EVER vs TMO · P/E 6.6, rev $500.2M vs P/E 24, rev $44.56B
EverQuote Inc Class A (EVER) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
EverQuote Inc Class A (EVER) is a internet content & information company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported EVER revenue for 2024-12-31 was $500.2M. Net income was $32.2M. Revenue was up 73.7% from 2023-12-31 to 2024-12-31. EVER currently screens at market cap $683.4M and trailing P/E 6.6.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
EVER currently screens at market cap $683.4M and trailing P/E 6.6. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the EVER and TMO stock pages for the full models.
Not investment advice.